Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
54.48
+0.46 (0.85%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Monopar Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 61.83 | 45.82 | 7.27 | 8.19 | 20.3 | Upgrade
|
| Short-Term Investments | 78.57 | 14.4 | - | 4.93 | - | Upgrade
|
| Cash & Short-Term Investments | 140.4 | 60.21 | 7.27 | 13.12 | 20.3 | Upgrade
|
| Cash Growth | 133.17% | 728.67% | -44.62% | -35.38% | 21.31% | Upgrade
|
| Other Current Assets | 0.06 | 0.08 | 0.07 | 0.05 | 0.22 | Upgrade
|
| Total Current Assets | 140.46 | 60.29 | 7.33 | 13.17 | 20.52 | Upgrade
|
| Property, Plant & Equipment | 0.25 | - | 0.01 | 0.06 | - | Upgrade
|
| Total Assets | 140.72 | 60.29 | 7.35 | 13.23 | 20.52 | Upgrade
|
| Accounts Payable | 2.64 | 2.25 | 1.76 | 3.13 | 1.58 | Upgrade
|
| Accrued Expenses | - | 3 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.09 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 2.74 | 5.25 | 1.76 | 3.13 | 1.58 | Upgrade
|
| Long-Term Leases | 0.15 | - | - | 0.01 | - | Upgrade
|
| Total Liabilities | 2.89 | 5.25 | 1.76 | 3.14 | 1.58 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 227.2 | 130.79 | 65.81 | 61.87 | 60.22 | Upgrade
|
| Retained Earnings | -89.51 | -75.79 | -60.21 | -51.8 | -41.29 | Upgrade
|
| Comprehensive Income & Other | 0.13 | 0.04 | -0.01 | 0.01 | -0 | Upgrade
|
| Total Common Equity | 137.83 | 55.04 | 5.59 | 10.09 | 18.94 | Upgrade
|
| Shareholders' Equity | 137.83 | 55.04 | 5.59 | 10.09 | 18.94 | Upgrade
|
| Total Liabilities & Equity | 140.72 | 60.29 | 7.35 | 13.23 | 20.52 | Upgrade
|
| Total Debt | 0.25 | - | - | 0.01 | - | Upgrade
|
| Net Cash (Debt) | 140.15 | 60.21 | 7.27 | 13.11 | 20.3 | Upgrade
|
| Net Cash Growth | 132.77% | 728.67% | -44.58% | -35.42% | 21.31% | Upgrade
|
| Net Cash Per Share | 18.91 | 15.89 | 2.63 | 5.15 | 8.14 | Upgrade
|
| Filing Date Shares Outstanding | 6.69 | 6.11 | 3.49 | 2.64 | 2.52 | Upgrade
|
| Total Common Shares Outstanding | 6.69 | 6.1 | 2.98 | 2.59 | 2.52 | Upgrade
|
| Working Capital | 137.73 | 55.04 | 5.58 | 10.04 | 18.94 | Upgrade
|
| Book Value Per Share | 20.60 | 9.02 | 1.87 | 3.90 | 7.52 | Upgrade
|
| Tangible Book Value | 137.83 | 55.04 | 5.59 | 10.09 | 18.94 | Upgrade
|
| Tangible Book Value Per Share | 20.60 | 9.02 | 1.87 | 3.90 | 7.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.